Company Filing History:
4 out of 4 
2 out of 2 
2 out of 4 Years Active: 2014-2025
Title: Innovations by Inventor Miguel De Los Rios in Treating Fibrosis
Introduction
Miguel De Los Rios is an innovative inventor based in Del Mar, CA, who has made significant contributions to the medical field with his extensive research and development. He holds a total of seven patents, showcasing his dedication to advancing treatment methods, particularly in the area of fibrosis.
Latest Patents
Among his latest innovations are methods of treating fibrosis. The specifications outline novel methods and compositions specifically aimed at treating pulmonary fibrosis. This condition may be idiopathic or may arise following a lung infection, including infections caused by SARS-CoV-2. As a result of his treatment methods, lung function in patients is shown to stabilize or improve, providing hope to those affected by this debilitating condition.
Career Highlights
Throughout his career, Miguel has contributed to various organizations that focus on biomedical innovations. Notably, he has worked with Endeavor Biomedicines, Inc., where he has furthered his research in the field of fibrotic diseases. Additionally, his tenure at Biomed Realty, L.P. has allowed him to collaborate with professionals in the biotechnology industry, enhancing his impact on medical advancements.
Collaborations
Miguel’s achievements have been supported by collaborative efforts with other professionals in the field. He has worked alongside notable colleagues such as Anita Difrancesco and Stephanie De Los Rios. These collaborations have not only enriched his research but have also helped in the successful development of his treatment methodologies.
Conclusion
In summary, Miguel De Los Rios stands out as an influential inventor dedicated to improving patient outcomes in the field of fibrosis treatment. His innovative patents and collaborations reflect a commitment to paving the way for advancements in medical research and healthcare solutions. As he continues to explore new frontiers, the medical community anticipates further breakthroughs that could enhance the lives of those suffering from complex lung conditions.